PREVALENCE OF CHRONIC KIDNEY DISEASE STAGES 4 AND 5ND AMONG PATIENTS WITH TUBERCULOSIS

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

Presented the abstract " "
(Abstract co-author(s): )

Back

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

Abstract Title *

PREVALENCE OF CHRONIC KIDNEY DISEASE STAGES 4 AND 5ND AMONG PATIENTS WITH TUBERCULOSIS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

The title will not be accepted if it exceeds 25 words.
Type in CAPITAL LETTERS.
Lowercase may be used for abbreviations only, for example, mRNA.

Co-author 1

Muhammad Rahim muradrahim23@yahoo.com BIRDEM General Hospital Nephrology Dhaka Bangladesh *

Co-author 2

Mohammad Hossain delwarhschest@yahoo.com BIRDEM General Hospital Respiratory Medicine Dhaka Bangladesh -

Co-author 3

Mohammad Habib dr.afsarul.habib@gmail.com BIRDEM General Hospital BADAS TB Initiative Dhaka Bangladesh -

Co-author 4

Syeda Efa badas.tbi.dr.efa@gmail.com BIRDEM General Hospital BADAS TB Initiative BADAS TB Initiative Bangladesh -

Co-author 5

Kaniz Afrin badas.tbi.drkanizafrin@gmail.com BIRDEM General Hospital BADAS TB Initiative BADAS TB Initiative Bangladesh -

Co-author 6

Farhana Afroz lubna0408@gmail.com BIRDEM General Hospital Respiratory Medicine Dhaka Bangladesh -

Co-author 7

Mohammad Mehfuz-E-Khoda mehfuzek@gmail.com BIRDEM General Hospital Nephrology Dhaka Bangladesh -

Co-author 8

Md. Billah drbillah70@gmail.com BIRDEM General Hospital Nephrology Dhaka Bangladesh -

Co-author 9

Abdul Latif dralatif78@gmail.com BIRDEM General Hospital Nephrology Dhaka Bangladesh -

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15

Introduction

Tuberculosis remains as a major global health issue and chronic kidney disease (CKD) is an emerging global epidemic. Presence of CKD and a low glomerular filtration rate (GFR) require modifications in anti-tuberculosis drug dosage. This study was designed to evaluate the prevalence of CKD stage 4 and non-dialysis dependent stage 5 (CKD stages 4 and 5ND) among patients diagnosed with tuberculosis.

Methods

This cross-sectional study was done at BIRDEM General Hospital, Dhaka, Bangladesh over a period of seven years (2018 – 2024). Tuberculosis was diagnosed as per the Bangladesh National Guidelines for Tuberculosis Infection Control, 2011. Diagnosis and staging of CKD was done following the KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

Results

Total number of patients were 2625 with male (1675, 63.8%) predominance. Most (2003, 76.3%) patients were diabetic, 814 (31%) were smokers and 237 (9%) had a past history of tuberculosis. Diabetic patients were older than non-diabetic patients (mean age, 49.6 ± 13.2 vs 31.1 ± 16.9 years, p < 0.05) and had a higher body mass index (BMI) (21.1 ± 4.1 vs 20.4 ± 4.9 kg/m2, p < 0.05). Total 1756 (66.9%) patients had pulmonary tuberculosis (1468/2003, 73.3% in diabetic and 288/622, 46.3% in non-diabetic patients, p<0.05). A total of 49 (1.87%) patients had CKD stages 4 and 5ND, 43 (43/2003, 2.1%) in diabetic and 6 (6/622, 0.96%) in non-diabetic patients (p 0.85).

Conclusion

Almost 2% of patients with tuberculosis had CKD stages 4 and 5ND and the prevalence was two times more common among diabetic patients compared to non-diabetic patients.

Kewords